NIH-funded research NIH-funded research

A rapid test for detecting HIV-1 using CRISPR technology

Official title: CRISPR-Cas13-based rapid HIV-1 test

Funded at Rice University · NIH-11009060 · Data updated 2026-11-12

This study is working on a simple and fast way for people to test themselves for HIV-1 using a new technology that can detect the virus in blood or saliva without needing special equipment, making it easier for everyone to get tested and find out their status early.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRice University
NIH-funded
Lab location1 site (Houston, United States)
Project startJanuary 24, 2023
Project endDecember 31, 2025
Funding year2025
Award (this year)$449,074
NIH project number5R61AI167037-03
Project IDNIH-11009060 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of HIV infection or those who may have recently been exposed to the virus.

Less likely to help

Patients who are already diagnosed with HIV and are receiving effective antiretroviral therapy may not benefit from this research.

What this research studies

This research aims to develop a quick and sensitive test for HIV-1 that can be performed without specialized equipment. It focuses on using CRISPR-Cas13 technology to detect the virus in blood or saliva, making it easier for individuals to test themselves. The test is designed to be shelf-stable and user-friendly, addressing the limitations of current testing methods that require complex procedures and refrigeration. By simplifying the testing process, this research hopes to improve early detection of HIV, especially during acute infections.

Why it matters

Potential benefit: If successful, this research could provide a more accessible and accurate method for early detection of HIV-1, potentially reducing transmission rates.

How similar studies have gone: Other research has shown promise in using CRISPR technology for rapid diagnostics, indicating potential success for this novel approach.

Where this research is happening

  • Rice University
    Houston, United States
    Active

Researchers

  • Principal investigator: Lillehoj, Peter B — Rice University
  • Study coordinator: Lillehoj, Peter B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.